Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2673

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1
Chunk 2673
---
 stock to decline.

We
will incur increased costs as a result of operating as a public company, and our management will devote substantial time to compliance
with its public company responsibilities and corporate governance practices.

As
a public company, we will incur significant legal, accounting and other expenses that Legacy Ocean did not incur as a private company,
and these expenses may increase even more after we are no longer an emerging growth company, as defined in Section 2(a) of the Securities
Act.

We
are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, which require, among other things, that
we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley
Act, as well as rules subsequently adopted by the SEC and Nasdaq to implement provisions of the Sarbanes-Oxley Act, impose significant
requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting controls
and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act,
or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank
Act that require the SEC to adopt additional rules and regulations in these areas such as “say on pay” and proxy access.
EGCs are permitted to implement many of these requirements over a longer period. Stockholder activism, the current political environment
and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations,
which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.

We
expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and
to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from
other business concerns, they could have an adverse effect on our business. The increased costs will decrease our net income or increase
our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. We
cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these
requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our
board committees or as executive officers.

Our